Press monitoring
Genetically Modified Stem Cells May Have Therapeutic Application to X-SCID
3.6.2007 | Press monitoring
A study demonstrating therapeutic utilization of human stem cells, including potential application to X-linked Severe Combined Immunodeficiency (XSCID or “Bubble-Boy” disease) was presented today at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
Discovery could lead to cancer blood test
2.6.2007 | Press monitoring
Researchers in Oregon say they've identified a protein marker for prostate cancer survival.
Nanoparticle Self-Assembly Triggered by Tumor-Associated Enzyme
1.6.2007 | Press monitoring
There is a growing recognition among cancer researchers that the most accurate methods for detecting early-stage cancer will require the development of sensitive assays that can identify simultaneously multiple biomarkers associated with malignant cells.
Geneticists create 'next generation' of GM crops
31.5.2007 | Press monitoring
Researchers have created what could be the next generation of transgenic crops by inserting a gene for herbicide resistance from a bacterium into plants. The new crops could help to combat the spread of resistance to other commonly used herbicides.
Scientists find bird flu antibody
30.5.2007 | Press monitoring
Antibodies that could protect against bird flu in humans have been isolated by an international team of scientists.
Scientists breed skim milk-producing cow
29.5.2007 | Press monitoring
Scientists in New Zealand have successfully bred a cow that produces skim milk and the firm behind the process said herds of the animals are on the horizon.
Genome of Clostridium Botulinum Reveals The Background To World's Deadliest Toxin
28.5.2007 | Press monitoring
The genome of the organism that produces the world's most lethal toxin is revealed today. This toxin is the one real weapon in the genome of Clostridium botulinum and less than 2 kg — the weight of two bags of sugar — is enough to kill every person on the planet. Very small amounts of the same toxin are used in medical treatments, one of which is...
Researcher Announced Cure for Hepatitis C
25.5.2007 | Press monitoring
The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today.
University group sues Monsanto over soybean patent
24.5.2007 | Press monitoring
A crop technology research group tied to Iowa State University has accused agricultural biotechnology leader Monsanto Co. of "willful and wanton" infringement on patented technology involving a popular new type of soybean.
Nanoparticles Delivery of 'Suicide DNA' Kills Prostate Tumors
24.5.2007 | Press monitoring
Using nanoparticles developed by members of the Alliance for Nanotechnology in Cancer, a team of investigators at the Lankenau Institute for Medical Research, in Philadelphia, has developed a DNA-based therapeutic agent that has the potential to treat both enlarged prostates and localized prostate tumors. When tested in mice, this new agent...
